GE HealthCare to buy Sofie Biosciences for $945 million to grow medical-imaging business

GE HealthCare is expected to announce Monday a $945 million cash acquisition of Sofie Biosciences, a manufacturer of radioactive substances used in medical-imaging procedures such as PET scans, in a deal aimed at growing its imaging business.

Detected & updated continuously · Source: Nebula